News + Filings Transactions
|
Shemesh Shay
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 03/21/2023 | Nuvectis Pharma, Inc. | | Purchase | Common Stock | 420 | $11.99 | $5k | | 03/21/2023 |
| 03/15/2023 | Nuvectis Pharma, Inc. | | Purchase | Common Stock | 670 | $10.71 | $7.2k | | 03/15/2023 |
| 01/12/2023 | Nuvectis Pharma, Inc. | | Grant | Common Stock | 115k | $0.00 | $0 | | 01/12/2023 |
| 12/21/2022 | Nuvectis Pharma, Inc. | | Purchase | Common Stock | 500 | $7.65 | $3.8k | | 12/21/2022 |
| 11/17/2022 | Nuvectis Pharma, Inc. | | Purchase | Common Stock | 150 | $7.20 | $1.1k | | 11/16/2022 |
| 11/16/2022 | Nuvectis Pharma, Inc. | | Purchase | Common Stock | 150 | $7.10 | $1.1k | | 11/16/2022 |
| 09/23/2022 | Nuvectis Pharma, Inc. | | Purchase | Common Stock | 220 | $7.87 | $1.7k | | 09/23/2022 |
| 09/02/2022 | Nuvectis Pharma, Inc. | | Purchase | Common Stock | 404 | $8.31 | $3.4k | | 09/02/2022 |
| 09/01/2022 | Nuvectis Pharma, Inc. | | Purchase | Common Stock | 1.5k | $8.07 | $12.3k | | 08/31/2022 |
| 08/31/2022 | Nuvectis Pharma, Inc. | | Purchase | Common Stock | 1.5k | $8.07 | $11.9k | | 08/31/2022 |
| 05/20/2022 | Nuvectis Pharma, Inc. | | Purchase | Common Stock | 300 | $16.54 | $5k | | 05/20/2022 |
| 05/17/2022 | Nuvectis Pharma, Inc. | | Purchase | Common Stock | 142 | $19.55 | $2.8k | | 05/16/2022 |
| 05/16/2022 | Nuvectis Pharma, Inc. | | Purchase | Common Stock | 100 | $19.28 | $1.9k | | 05/16/2022 |
| 05/12/2022 | Nuvectis Pharma, Inc. | | Purchase | Common Stock | 36 | $14.58 | $524.9 | | 05/12/2022 |
| 05/12/2022 | Nuvectis Pharma, Inc. | | Purchase | Common Stock | 1.2k | $15.85 | $18.8k | | 05/12/2022 |
| 05/12/2022 | Nuvectis Pharma, Inc. | | Purchase | Common Stock | 58 | $16.61 | $963.4 | | 05/12/2022 |
| 04/01/2022 | Nuvectis Pharma, Inc. | | Grant | Common Stock | 60k | $0.00 | $0 | | 04/01/2022 |
| 02/07/2022 | Nuvectis Pharma, Inc. | | Purchase | Common Stock, par value $0.00001 | 846 | $3.47 | $2.9k | | 02/04/2022 |
| 02/04/2022 | Nuvectis Pharma, Inc. | | Purchase | Common Stock, par value $0.00001 | 2.1k | $3.38 | $7.1k | | 02/04/2022 |
|